IL17A and dermatophytosis: From an immunological perspective, patients with chronic dermatophytosis often exhibit reduced interferon levels, decreased type 1 helper (Th1) and interleukin-17 (IL-17)-positive Th17 cells, and an impaired immune response, particularly in delayed-type hypersensitivity reactions observed in intradermal tests [9].